Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Diabetes & Metabolic Syndrome|August 20, 2019
Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetesElamin Abdelgadir, Fauzia Rashid, Alaaeldin Bashier, et al.Diabetes Research and Clinical Practice|November 10, 2025
Meta-analysis on the validity and clinical utility of the IDF/DAR risk stratification toolElamin Abdelgadir, Mohamed Hassanein, Salem Beshyah, et al.Diabetes & Metabolic Syndrome|January 16, 2019
Glycemic and lipids control in patients with diabetes and cardiovascular or renal diseases across all the government health sectors in the Emirate of Dubai, United Arab EmiratesFauzia Rashid, Elamin Abdelgadir, Maryam Alsaeed, et al.Diabetes & Metabolic Syndrome|June 26, 2019
Should metformin still be the first-line of treatment in type 2 diabetes mellitus? A comprehensive review and suggested algorithmAzza Khalifa Bin Hussain, Elamin Abdelgadir, Fauzia Rashid, et al.Canadian Journal of Diabetes|July 25, 2025
In The Eye Of Controversy: A Deeper Look Into The Impact Of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RA) on Diabetic Retinopathy and Non-arteritic anterior ischemic optic neuropathy (NAION)Nadia Nadeem, Raghad Mazin Al Issa, Asnin Shah, et al.Oman Medical Journal|July 31, 2019
Lipid Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in Dubai: A Five-year PatternElamin Abdelgadir, Maryam Alsaeed, Khadija Hafidh, et al.American Heart Journal Plus : Cardiology Research and Practice|February 25, 2025
Reduced retinal microvascular density in women with coronary microvascular dysfunction: A pilot studySakshi Shiromani, Ahmed AlBadri, Aaron Lindeke-Myers, et al.Oman Medical Journal|January 24, 2019
Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year PatternFatheya Alawadi, Elamin Abdelgadir, Alaaeldin Bashier, et al.Journal of Clinical Medicine Research|May 13, 2017
Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 DiabetesAlaaeldin Bashier, Azza Abdulaziz Khalifa, Fauzia Rashid, et al.Diabetes Research and Clinical Practice|January 15, 2019
The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetesMohamed Hassanein, Elamin Abdelgadir, Alaaeldin Bashier, et al.Pageof 3